Loading…
Manifesto for a European Anxiety Disorders Research Network
Abstract Despite the size, burden and costs of anxiety disorders, many patients remain unrecognised, and the effectiveness of evidence-based interventions in routine clinical practice can be disappointing. The European College of Neuropsychopharmacology (ECNP) has established the ECNP Network Initia...
Saved in:
| Published in: | European neuropsychopharmacology 2010-06, Vol.20 (6), p.426-432 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c570t-d8b506e2f22c912efc5199bcfff6ce513f8cb915f7d9685ed2f73d95e378de0d3 |
|---|---|
| cites | |
| container_end_page | 432 |
| container_issue | 6 |
| container_start_page | 426 |
| container_title | European neuropsychopharmacology |
| container_volume | 20 |
| creator | Baldwin, David S Allgulander, Christer Altamura, Alfredo Carlo Angst, Jules Bandelow, Borwin den Boer, Johan Boyer, Patrice Davies, Simon dell'Osso, Bernardo Eriksson, Elias Fineberg, Naomi Fredrikson, Mats Herran, Andres Maron, Eduard Metspalu, Andres Nutt, David van der Wee, Nic Vázquez-Barquero, Jose Luis Zohar, Joseph |
| description | Abstract Despite the size, burden and costs of anxiety disorders, many patients remain unrecognised, and the effectiveness of evidence-based interventions in routine clinical practice can be disappointing. The European College of Neuropsychopharmacology (ECNP) has established the ECNP Network Initiative (ECNP-NI) to help meet the goal of extending current understanding of the causes of central nervous system disorders, thereby contributing to improvements in clinical outcomes and reducing the associated societal burden. The Anxiety Disorders Research Network (ADRN) has been adopted within the ECNP-NI: this consensus statement summarises its overall aims and objectives. |
| doi_str_mv | 10.1016/j.euroneuro.2010.02.015 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_552250</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0924977X10000489</els_id><sourcerecordid>733947187</sourcerecordid><originalsourceid>FETCH-LOGICAL-c570t-d8b506e2f22c912efc5199bcfff6ce513f8cb915f7d9685ed2f73d95e378de0d3</originalsourceid><addsrcrecordid>eNqNkluv1CAQgInReNbVv6B988WuXEqBmJhszkVNjpp4i2-kpcPKXkqF4jn776XZdR9MvPAAZPLNDOEbhJ4QvCCY1M_XC0jB99O2oDhHMV1gwu-gGZGClULW9C6aYUWrUgnx9Qw9iHGNM8GYuo_OKGa8FkTM0Iu3Te8sxNEX1oeiKS5zyQGavlj2tw7GfXHhog8dhFh8gAhNMN-KdzDe-LB5iO7ZZhvh0fGco89Xl5_OX5fX71-9OV9el4YLPJadbDmugVpKjSIUrOFEqdZYa2sDnDArTasIt6JTteTQUStYpzgwITvAHZuj8lA33sCQWj0Et2vCXvvG6WNok2-gOaeU47_yqzToHFqliSeUYlll_tkf-Qv3Zal9WOmUMs4VVhl_esCH4L-n_HV656KB7bbpwaeopWS4UlVF_0mKbKMSk7E5EgfSBB9jAHt6BMF6Mq7X-mRcT8Y1pnryOUePjz1Su4PulPdLcQaWBwCyoh8Ogo7GQW-gcwHMqDvv_qPJy99qmK3rnWm2G9hDXPsU-jwBmuiYE_THafCmuSM4r0oq9hO55Ndl</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733947187</pqid></control><display><type>article</type><title>Manifesto for a European Anxiety Disorders Research Network</title><source>ScienceDirect Journals</source><creator>Baldwin, David S ; Allgulander, Christer ; Altamura, Alfredo Carlo ; Angst, Jules ; Bandelow, Borwin ; den Boer, Johan ; Boyer, Patrice ; Davies, Simon ; dell'Osso, Bernardo ; Eriksson, Elias ; Fineberg, Naomi ; Fredrikson, Mats ; Herran, Andres ; Maron, Eduard ; Metspalu, Andres ; Nutt, David ; van der Wee, Nic ; Vázquez-Barquero, Jose Luis ; Zohar, Joseph</creator><creatorcontrib>Baldwin, David S ; Allgulander, Christer ; Altamura, Alfredo Carlo ; Angst, Jules ; Bandelow, Borwin ; den Boer, Johan ; Boyer, Patrice ; Davies, Simon ; dell'Osso, Bernardo ; Eriksson, Elias ; Fineberg, Naomi ; Fredrikson, Mats ; Herran, Andres ; Maron, Eduard ; Metspalu, Andres ; Nutt, David ; van der Wee, Nic ; Vázquez-Barquero, Jose Luis ; Zohar, Joseph</creatorcontrib><description>Abstract Despite the size, burden and costs of anxiety disorders, many patients remain unrecognised, and the effectiveness of evidence-based interventions in routine clinical practice can be disappointing. The European College of Neuropsychopharmacology (ECNP) has established the ECNP Network Initiative (ECNP-NI) to help meet the goal of extending current understanding of the causes of central nervous system disorders, thereby contributing to improvements in clinical outcomes and reducing the associated societal burden. The Anxiety Disorders Research Network (ADRN) has been adopted within the ECNP-NI: this consensus statement summarises its overall aims and objectives.</description><identifier>ISSN: 0924-977X</identifier><identifier>ISSN: 1873-7862</identifier><identifier>EISSN: 1873-7862</identifier><identifier>DOI: 10.1016/j.euroneuro.2010.02.015</identifier><identifier>PMID: 20356717</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Anti-Anxiety Agents - therapeutic use ; Anxiety disorders ; Anxiety Disorders - complications ; Anxiety Disorders - diagnosis ; Anxiety Disorders - economics ; Anxiety Disorders - epidemiology ; Anxiety Disorders - therapy ; Comorbidity ; Consensus ; Cost of Illness ; Culture ; Europe - epidemiology ; Farmakologi och toxikologi ; Humans ; Internal Medicine ; Multicenter Studies as Topic ; network ; Outcomes ; Pharmacology and Toxicology ; Psychiatry ; Psychology ; Psykologi ; Public Health ; Research network ; Research Support as Topic ; SAMHÄLLSVETENSKAP ; SOCIAL SCIENCES ; Socialvetenskap ; Treatment ; Treatment Failure</subject><ispartof>European neuropsychopharmacology, 2010-06, Vol.20 (6), p.426-432</ispartof><rights>Elsevier B.V. and ECNP</rights><rights>2010 Elsevier B.V. and ECNP</rights><rights>2010 Elsevier B.V. and ECNP. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c570t-d8b506e2f22c912efc5199bcfff6ce513f8cb915f7d9685ed2f73d95e378de0d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,778,782,883,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20356717$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-125909$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttps://gup.ub.gu.se/publication/122084$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:120585937$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Baldwin, David S</creatorcontrib><creatorcontrib>Allgulander, Christer</creatorcontrib><creatorcontrib>Altamura, Alfredo Carlo</creatorcontrib><creatorcontrib>Angst, Jules</creatorcontrib><creatorcontrib>Bandelow, Borwin</creatorcontrib><creatorcontrib>den Boer, Johan</creatorcontrib><creatorcontrib>Boyer, Patrice</creatorcontrib><creatorcontrib>Davies, Simon</creatorcontrib><creatorcontrib>dell'Osso, Bernardo</creatorcontrib><creatorcontrib>Eriksson, Elias</creatorcontrib><creatorcontrib>Fineberg, Naomi</creatorcontrib><creatorcontrib>Fredrikson, Mats</creatorcontrib><creatorcontrib>Herran, Andres</creatorcontrib><creatorcontrib>Maron, Eduard</creatorcontrib><creatorcontrib>Metspalu, Andres</creatorcontrib><creatorcontrib>Nutt, David</creatorcontrib><creatorcontrib>van der Wee, Nic</creatorcontrib><creatorcontrib>Vázquez-Barquero, Jose Luis</creatorcontrib><creatorcontrib>Zohar, Joseph</creatorcontrib><title>Manifesto for a European Anxiety Disorders Research Network</title><title>European neuropsychopharmacology</title><addtitle>Eur Neuropsychopharmacol</addtitle><description>Abstract Despite the size, burden and costs of anxiety disorders, many patients remain unrecognised, and the effectiveness of evidence-based interventions in routine clinical practice can be disappointing. The European College of Neuropsychopharmacology (ECNP) has established the ECNP Network Initiative (ECNP-NI) to help meet the goal of extending current understanding of the causes of central nervous system disorders, thereby contributing to improvements in clinical outcomes and reducing the associated societal burden. The Anxiety Disorders Research Network (ADRN) has been adopted within the ECNP-NI: this consensus statement summarises its overall aims and objectives.</description><subject>Anti-Anxiety Agents - therapeutic use</subject><subject>Anxiety disorders</subject><subject>Anxiety Disorders - complications</subject><subject>Anxiety Disorders - diagnosis</subject><subject>Anxiety Disorders - economics</subject><subject>Anxiety Disorders - epidemiology</subject><subject>Anxiety Disorders - therapy</subject><subject>Comorbidity</subject><subject>Consensus</subject><subject>Cost of Illness</subject><subject>Culture</subject><subject>Europe - epidemiology</subject><subject>Farmakologi och toxikologi</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Multicenter Studies as Topic</subject><subject>network</subject><subject>Outcomes</subject><subject>Pharmacology and Toxicology</subject><subject>Psychiatry</subject><subject>Psychology</subject><subject>Psykologi</subject><subject>Public Health</subject><subject>Research network</subject><subject>Research Support as Topic</subject><subject>SAMHÄLLSVETENSKAP</subject><subject>SOCIAL SCIENCES</subject><subject>Socialvetenskap</subject><subject>Treatment</subject><subject>Treatment Failure</subject><issn>0924-977X</issn><issn>1873-7862</issn><issn>1873-7862</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqNkluv1CAQgInReNbVv6B988WuXEqBmJhszkVNjpp4i2-kpcPKXkqF4jn776XZdR9MvPAAZPLNDOEbhJ4QvCCY1M_XC0jB99O2oDhHMV1gwu-gGZGClULW9C6aYUWrUgnx9Qw9iHGNM8GYuo_OKGa8FkTM0Iu3Te8sxNEX1oeiKS5zyQGavlj2tw7GfXHhog8dhFh8gAhNMN-KdzDe-LB5iO7ZZhvh0fGco89Xl5_OX5fX71-9OV9el4YLPJadbDmugVpKjSIUrOFEqdZYa2sDnDArTasIt6JTteTQUStYpzgwITvAHZuj8lA33sCQWj0Et2vCXvvG6WNok2-gOaeU47_yqzToHFqliSeUYlll_tkf-Qv3Zal9WOmUMs4VVhl_esCH4L-n_HV656KB7bbpwaeopWS4UlVF_0mKbKMSk7E5EgfSBB9jAHt6BMF6Mq7X-mRcT8Y1pnryOUePjz1Su4PulPdLcQaWBwCyoh8Ogo7GQW-gcwHMqDvv_qPJy99qmK3rnWm2G9hDXPsU-jwBmuiYE_THafCmuSM4r0oq9hO55Ndl</recordid><startdate>20100601</startdate><enddate>20100601</enddate><creator>Baldwin, David S</creator><creator>Allgulander, Christer</creator><creator>Altamura, Alfredo Carlo</creator><creator>Angst, Jules</creator><creator>Bandelow, Borwin</creator><creator>den Boer, Johan</creator><creator>Boyer, Patrice</creator><creator>Davies, Simon</creator><creator>dell'Osso, Bernardo</creator><creator>Eriksson, Elias</creator><creator>Fineberg, Naomi</creator><creator>Fredrikson, Mats</creator><creator>Herran, Andres</creator><creator>Maron, Eduard</creator><creator>Metspalu, Andres</creator><creator>Nutt, David</creator><creator>van der Wee, Nic</creator><creator>Vázquez-Barquero, Jose Luis</creator><creator>Zohar, Joseph</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>DF2</scope><scope>F1U</scope></search><sort><creationdate>20100601</creationdate><title>Manifesto for a European Anxiety Disorders Research Network</title><author>Baldwin, David S ; Allgulander, Christer ; Altamura, Alfredo Carlo ; Angst, Jules ; Bandelow, Borwin ; den Boer, Johan ; Boyer, Patrice ; Davies, Simon ; dell'Osso, Bernardo ; Eriksson, Elias ; Fineberg, Naomi ; Fredrikson, Mats ; Herran, Andres ; Maron, Eduard ; Metspalu, Andres ; Nutt, David ; van der Wee, Nic ; Vázquez-Barquero, Jose Luis ; Zohar, Joseph</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c570t-d8b506e2f22c912efc5199bcfff6ce513f8cb915f7d9685ed2f73d95e378de0d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Anti-Anxiety Agents - therapeutic use</topic><topic>Anxiety disorders</topic><topic>Anxiety Disorders - complications</topic><topic>Anxiety Disorders - diagnosis</topic><topic>Anxiety Disorders - economics</topic><topic>Anxiety Disorders - epidemiology</topic><topic>Anxiety Disorders - therapy</topic><topic>Comorbidity</topic><topic>Consensus</topic><topic>Cost of Illness</topic><topic>Culture</topic><topic>Europe - epidemiology</topic><topic>Farmakologi och toxikologi</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Multicenter Studies as Topic</topic><topic>network</topic><topic>Outcomes</topic><topic>Pharmacology and Toxicology</topic><topic>Psychiatry</topic><topic>Psychology</topic><topic>Psykologi</topic><topic>Public Health</topic><topic>Research network</topic><topic>Research Support as Topic</topic><topic>SAMHÄLLSVETENSKAP</topic><topic>SOCIAL SCIENCES</topic><topic>Socialvetenskap</topic><topic>Treatment</topic><topic>Treatment Failure</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baldwin, David S</creatorcontrib><creatorcontrib>Allgulander, Christer</creatorcontrib><creatorcontrib>Altamura, Alfredo Carlo</creatorcontrib><creatorcontrib>Angst, Jules</creatorcontrib><creatorcontrib>Bandelow, Borwin</creatorcontrib><creatorcontrib>den Boer, Johan</creatorcontrib><creatorcontrib>Boyer, Patrice</creatorcontrib><creatorcontrib>Davies, Simon</creatorcontrib><creatorcontrib>dell'Osso, Bernardo</creatorcontrib><creatorcontrib>Eriksson, Elias</creatorcontrib><creatorcontrib>Fineberg, Naomi</creatorcontrib><creatorcontrib>Fredrikson, Mats</creatorcontrib><creatorcontrib>Herran, Andres</creatorcontrib><creatorcontrib>Maron, Eduard</creatorcontrib><creatorcontrib>Metspalu, Andres</creatorcontrib><creatorcontrib>Nutt, David</creatorcontrib><creatorcontrib>van der Wee, Nic</creatorcontrib><creatorcontrib>Vázquez-Barquero, Jose Luis</creatorcontrib><creatorcontrib>Zohar, Joseph</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Uppsala universitet</collection><collection>SWEPUB Göteborgs universitet</collection><jtitle>European neuropsychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baldwin, David S</au><au>Allgulander, Christer</au><au>Altamura, Alfredo Carlo</au><au>Angst, Jules</au><au>Bandelow, Borwin</au><au>den Boer, Johan</au><au>Boyer, Patrice</au><au>Davies, Simon</au><au>dell'Osso, Bernardo</au><au>Eriksson, Elias</au><au>Fineberg, Naomi</au><au>Fredrikson, Mats</au><au>Herran, Andres</au><au>Maron, Eduard</au><au>Metspalu, Andres</au><au>Nutt, David</au><au>van der Wee, Nic</au><au>Vázquez-Barquero, Jose Luis</au><au>Zohar, Joseph</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Manifesto for a European Anxiety Disorders Research Network</atitle><jtitle>European neuropsychopharmacology</jtitle><addtitle>Eur Neuropsychopharmacol</addtitle><date>2010-06-01</date><risdate>2010</risdate><volume>20</volume><issue>6</issue><spage>426</spage><epage>432</epage><pages>426-432</pages><issn>0924-977X</issn><issn>1873-7862</issn><eissn>1873-7862</eissn><abstract>Abstract Despite the size, burden and costs of anxiety disorders, many patients remain unrecognised, and the effectiveness of evidence-based interventions in routine clinical practice can be disappointing. The European College of Neuropsychopharmacology (ECNP) has established the ECNP Network Initiative (ECNP-NI) to help meet the goal of extending current understanding of the causes of central nervous system disorders, thereby contributing to improvements in clinical outcomes and reducing the associated societal burden. The Anxiety Disorders Research Network (ADRN) has been adopted within the ECNP-NI: this consensus statement summarises its overall aims and objectives.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>20356717</pmid><doi>10.1016/j.euroneuro.2010.02.015</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0924-977X |
| ispartof | European neuropsychopharmacology, 2010-06, Vol.20 (6), p.426-432 |
| issn | 0924-977X 1873-7862 1873-7862 |
| language | eng |
| recordid | cdi_swepub_primary_oai_swepub_ki_se_552250 |
| source | ScienceDirect Journals |
| subjects | Anti-Anxiety Agents - therapeutic use Anxiety disorders Anxiety Disorders - complications Anxiety Disorders - diagnosis Anxiety Disorders - economics Anxiety Disorders - epidemiology Anxiety Disorders - therapy Comorbidity Consensus Cost of Illness Culture Europe - epidemiology Farmakologi och toxikologi Humans Internal Medicine Multicenter Studies as Topic network Outcomes Pharmacology and Toxicology Psychiatry Psychology Psykologi Public Health Research network Research Support as Topic SAMHÄLLSVETENSKAP SOCIAL SCIENCES Socialvetenskap Treatment Treatment Failure |
| title | Manifesto for a European Anxiety Disorders Research Network |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T04%3A50%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Manifesto%20for%20a%20European%20Anxiety%20Disorders%20Research%20Network&rft.jtitle=European%20neuropsychopharmacology&rft.au=Baldwin,%20David%20S&rft.date=2010-06-01&rft.volume=20&rft.issue=6&rft.spage=426&rft.epage=432&rft.pages=426-432&rft.issn=0924-977X&rft.eissn=1873-7862&rft_id=info:doi/10.1016/j.euroneuro.2010.02.015&rft_dat=%3Cproquest_swepu%3E733947187%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c570t-d8b506e2f22c912efc5199bcfff6ce513f8cb915f7d9685ed2f73d95e378de0d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733947187&rft_id=info:pmid/20356717&rfr_iscdi=true |